InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.38
(
0.13%
)
US TECH 100
17,632.00
(
0.12%
)
Dow Jones
38,960.30
(
0.28%
)
Brent Oil
82.65
(
-0.99%
)
Bitcoin
63,281.46
(
0.18%
)
Post# of 251733
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 828
Posts 119580
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bickema post# 212682

Wednesday, 07/26/2017 7:22:26 PM

Wednesday, July 26, 2017 7:22:26 PM

Post# of 251733

EGRX—...do you think Eli Lilly will file a lawsuit before or after the PDUFA date for [505b2] Pemetrexed?

Good question. LLY didn't sue upon notification of EGRX's 505b2 application, which would have afforded LLY an automatic 30-month stay on FDA approval of EGRX's product. So, I'm not sure how LLY intends to play this.

Since LLY's US CoM patent on Alimta has expired, the question is whether LLY intends to prosecute the '209 patent that covers dosing of Alimta in combination with vitamin B12 and folic acid (https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=021462&Appl_type=N ).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up